A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed
- DOI
- 10.1080/14796694.2026.2739188
- Published
- 2026-09-26
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2739188,
title = {A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed},
author = {Jianxing He and Walter Weder and Ke-Neng Chen and Maximilian J. Hochmair and Jin-Yuan Shih and Sung Yong Lee and Kang-Yun Lee and Viet Nhung Nguyen and Somcharoen Saeteng and Lunxu Liu and Ligang Xing and Nguyen Hoang Gia and Shuji Murakami and Yongtao Han and María Paz Saavedra and Seong Hoon Yoon and Carlos H.A. Teixeira and Carles Escriu and Alex Martinez-Martí and Collin M. Blakely and Yasushi Yatabe and Sanja Dacic and Yuri Rukazenkov and Xiangning Huang and Anupriya Dayal and Jamie E. Chaft and Unknown},
year = {2026},
journal = {Future Oncology},
doi = {10.1080/14796694.2026.2739188},
url = {https://doi.org/10.1080/14796694.2026.2739188}
}RIS
TY - JOUR TI - A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed AU - Jianxing He AU - Walter Weder AU - Ke-Neng Chen AU - Maximilian J. Hochmair AU - Jin-Yuan Shih AU - Sung Yong Lee AU - Kang-Yun Lee AU - Viet Nhung Nguyen AU - Somcharoen Saeteng AU - Lunxu Liu AU - Ligang Xing AU - Nguyen Hoang Gia AU - Shuji Murakami AU - Yongtao Han AU - María Paz Saavedra AU - Seong Hoon Yoon AU - Carlos H.A. Teixeira AU - Carles Escriu AU - Alex Martinez-Martí AU - Collin M. Blakely AU - Yasushi Yatabe AU - Sanja Dacic AU - Yuri Rukazenkov AU - Xiangning Huang AU - Anupriya Dayal AU - Jamie E. Chaft AU - Unknown PY - 2026 JO - Future Oncology DO - 10.1080/14796694.2026.2739188 UR - https://doi.org/10.1080/14796694.2026.2739188 ER -
APA
He, J., Weder, W., Chen, K., Hochmair, M. J., Shih, J., Lee, S. Y., Lee, K., Nguyen, V. N., Saeteng, S., Liu, L., Xing, L., Gia, N. H., Murakami, S., Han, Y., Saavedra, M. P., Yoon, S. H., Teixeira, C. H., Escriu, C., Martinez-Martí, A., Blakely, C. M., Yatabe, Y., Dacic, S., Rukazenkov, Y., Huang, X., Dayal, A., Chaft, J. E., & Unknown (2026). A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed. Future Oncology. https://doi.org/10.1080/14796694.2026.2739188
Source records
- crossref · retrieved 2026-11-08T19:20:28.942Z